isothermal amplification
The firm expects to soon carve out a share in the rapidly expanding point-of-care, infectious disease, molecular diagnostics market.
The firm will submit its SARS-CoV-2 test and Talis One instrument to the US Food and Drug Administration for Emergency Use Authorization in the second quarter.
Sense Biodetection Raises $50M in Series B Financing to Develop POC MDx Platform, SARS-CoV-2 Test
The firm said that it is developing its Veros platform using rapid molecular amplification technology to detect a variety of diseases at the
LumiraDx to Go Public on Nasdaq Through SPAC
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization
The assay from San Diego-based Cue is the first molecular test authorized by the US Food and Drug Administration for home use without a doctor's prescription.